Contrary to ER, HER2 expression is known to be less frequent in elderly patients with breast cancer; the proportion of cases with HER2 positive tumors is 4% in the cohort of over-60 years, while it is 9% in patients younger than 35 years [30, 34]. Here, ESR1 is linked to breast carcinoma.